SB 641
Acts of Assembly Chapter text (CHAP0208)
Office-based buprenorphine treatment; Board of Medicine to amend regulations.
- Virginia
- Senate
- Introduced Jan 14, 2026
- Session 2026
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Virginia’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
28 actions-
Acts of Assembly Chapter text (CHAP0208)
-
Approved by Governor-Chapter 208 (effective 7/1/2026)
-
Governor's Action Deadline 11:59 p.m., April 13, 2026
-
Enrolled Bill communicated to Governor on March 10, 2026
-
Fiscal Impact statement From DPB (3/2/2026 2:20 pm)
-
Signed by President
-
Signed by Speaker
-
Bill text as passed Senate and House (SB641ER)
-
Enrolled
-
Passed House (98-Y 0-N 0-A)
-
Read third time
-
Read second time
-
Reported from Health and Human Services (21-Y 0-N)
-
Referred to Committee on Health and Human Services
-
Read first time
-
Placed on Calendar
-
Read third time and passed Senate (40-Y 0-N 0-A)
-
Engrossed by Senate (Voice Vote)
-
Read second time
-
Passed by for the day
-
Passed by for the day (Voice Vote)
-
Constitutional reading dispensed (on 1st reading) (39-Y 0-N 0-A)
-
Rules suspended
-
Reported from Education and Health (14-Y 0-N)
-
Assigned Education sub: Health Professions
-
Fiscal Impact Statement from Department of Planning and Budget (SB641)
-
Referred to Committee on Education and Health
-
Prefiled and ordered printed; Offered 01-14-2026 26104754D